Monday, February 14, 2011

Aging — Clinical Trials Exclude Patients Who May Benefit - NYTimes.com

Research. You can't live with it you can't without it. Research & studies that university & universities professors stake their financial lives on has had a history of blind spots. And this is another example one of them.

Can we recall how most if not ALL research on human subjects was mostly performed on men, college-aged men. It was assumed that the results of said research could be used for the "other sex" as well. Women argued for years that hormones have got to play a role in the reactions of medications and treatment plans. Was it not until the 1990's that the Women's Health Initiative was established. 1990's!!!!!!

Like no DUH!

Have you ever read a research study that within the conclusion states, that "more research is needed" to assume that this course of medication works across other population groups. Were those studies conducted or was the short-sighted results all that the was publicized. Could we have prevented many deaths from medication reactions?

Have we not seen how medications, meant for adults, are used for children. Just lesser mounts?! Anti-depression drugs comes to mind.

DUH!

Blind spots. This article demonstrates our continued blindness and dare I say neglect, of using sample groups from all populations who will make use of the drugs.

Research is good. It certainly can advance health care, but lets be sure we take the blinders off before we assume profit margins on the sell of those drugs...

A little oversight before we rush of to general conclusions would help. Rushing may help in short-term business profits, but good research should be more inclusive so we can reduce injury and possibly deaths.

Aging — Clinical Trials Exclude Patients Who May Benefit - NYTimes.com

No comments:

Post a Comment